Weight loss during prolonged branched-chain amino acid treatment for tardive dyskinesia in a patient with schizophrenia.
Gordon-Elliott
Janna S
JS
Margolese
Howard C
HC
D000597:Amino Acids, Branched-Chain / Q000494:pharmacology* / Q000627:therapeutic use*; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors; D000077236:Topiramate; D015431:Weight Loss / Q000187:drug effects*
D000597:Amino Acids, Branched-Chain; D019440:Anti-Obesity Agents; D005632:Fructose; D017367:Selective Serotonin Reuptake Inhibitors; D000077236:Topiramate